Sobre mi

Elias Campo es Catedràtic d ’Anatomia Patologica i Consultor Senior a l’Hospital Clínic, Universitat de Barcelona. La seva recerca es centra en la caracterització molecular de neoplàsies limfoides. En els últims anys el seu treball tracta d’elucidar les alteracions genòmiques i funcionals de la leucèmia limfàtica crònica, limfoma de cèl·lules del mantell i altres limfomes agressius i el seu impacte en entendre la seva patogènesis i el maneig dels pacients. Ha estat Co-Director del projecte Espanyol del genoma de la leucèmia limfàtica crònica en el International Cancer Genome Consortium . Es membre de la USA National Academy of Medicine des de 2018.

Publicacions destacades

  • The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee

    Autors: Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au WY, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d'Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD .
    Referència: Blood 2022.
  • Molecular map of chronic lymphocytic leukemia and its impact on outcome

    Autors: Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, Tausch E, Delgado J, Barbera-Mourelle A, Taylor-Weiner A, Bousquets-Muñoz P, Diaz-Navarro A, Dunford A, Anand S, Kretzmer H, Gutierrez-Abril J, López-Tamargo S, Fernandes SM, Sun C, Sivina M, Rassenti LZ, Schneider C, Li S, Parida L, Meissner A, Aguet F, Burger JA, Wiestner A, Kipps TJ, Brown JR, Hallek M, Stewart C, Neuberg DS, Martín-Subero JI, Puente XS, Stilgenbauer S, Wu CJ, Campo E, Getz G .
    Referència: Nature Genetics 2022.
  • Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    Autors: Nadeu F, Royo R, Massoni-Badosa R, Playa-Albinyana H, Garcia-Torre B, Duran-Ferrer M, Dawson KJ, Kulis M, Diaz-Navarro A, Villamor N, Melero JL, Chapaprieta V, Dueso-Barroso A, Delgado J, Moia R, Ruiz-Gil S, Marchese D, Giró A, Verdaguer-Dot N, Romo M, Clot G, Rozman M, Frigola G, Rivas-Delgado A, Baumann T, Alcoceba M, González M, Climent F, Abrisqueta P, Castellví J, Bosch F, Aymerich M, Enjuanes A, Ruiz-Gaspà S, López-Guillermo A, Jares P, Beà S, Capella-Gutierrez S, Gelpí JL, López-Bigas N, Torrents D, Campbell PJ, Gut I, Rossi D, Gaidano G, Puente XS, Garcia-Roves PM, Colomer D, Heyn H, Maura F, Martín-Subero JI, Campo E .
    Referència: Nature Medicine 2022.
  • IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

    Autors: Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martín S, Lu J, Zenz T, Baumann T, Jares P, Puente XS, Martín-Subero JI, Delgado J, Campo E .
    Referència: Blood 2021.
  • Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes

    Autors: Nadeu F, Martin-Garcia D, Clot G, Díaz-Navarro A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R, Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggros M, Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A, Ribera-Cortada I, Siebert R, Colomer D, Torrents D, Gine E, López-Guillermo A, Küppers R, Martin-Subero JI, Puente XS, Beà S, Campo E .
    Referència: Blood 2020.
  • IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

    Autors: Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S; Villamor, N; Suarez-Cisneros, H; Mares, R; Lu, JY; Enjuanes, A; Rivas-Delgado, A; Aymerich, M; Baumann, T; Colomer, D; Delgado, J; Morin, RD; Zenz, T; Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.
    Referència: Nature Communications 2020.
  • CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma

    Autors: Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S .
    Referència: Blood 2019.
  • A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

    Autors: Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina; Pinyol, Magda; Martin-Garcia, David; Demajo, Santiago; Espinet, Blanca; Salar, Antonio; Ferrer, Ana; Muntanola, Ana; Aymerich, Marta; Rauert-Wunderlich, Hilka; Jaffe, Elaine S.; Connors, Joseph M.; Gascoyne, Randy D.; Delabie, Jan; Lopez-Guillermo, Armando; Ott, German; Wright, George W.; Staudt, Louis M.; Rosenwald, Andreas; Scott, David W.; Rimsza, Lisa M.; Bea, Silvia; Campo, Elias;.
    Referència: Blood 2018.
  • Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

    Autors: Karube, K.; Enjuanes, A.; Dlouhy, I.; Jares, P.; Martin-Garcia, D.; Nadeu, F.; Ordonez, G. R.; Rovira, J.; Clot, G.; Royo, C.; Navarro, A.; Gonzalez-Farre, B.; Vaghefi, A.; Castellano, G.; Rubio-Perez, C.; Tamborero, D.; Briones, J.; Salar, A.; Sancho, J. M.; Mercadal, S.; Gonzalez-Barca, E.; Escoda, L.; Miyoshi, H.; Ohshima, K.; Miyawaki, K.; Kato, K.; Akashi, K.; Mozos, A.; Colomo, L.; Alcoceba, M.; Valera, A.; Carrio, A.; Costa, D.; Lopez-Bigas, N.; Schmitz, R.; Staudt, L. M.; Salaverria, I.; Lopez-Guillermo, A.; Campo, E.;.
    Referència: Leukemia 2018.
  • Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Autors: Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T; Salaverria, I; Bea, S; Pinyol, M; Jares, P; Navarro, A; Suarez-Cisneros, H; Aymerich, M; Rozman, M; Villamor, N; Colomer, D; Gonzalez, M; Alcoceba, M; Terol, MJ; Navarro, B; Colado, E; Payer, AR; Puente, XS; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.
    Referència: Leukemia 2018.

Projectes destacats

  • Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

    Investigador/a principal: Elías Campo Güerri
    Finançador: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)
    Codi: 1P01CA229100
    Durada: 01/09/2019 - 31/08/2024
  • Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

    Investigador/a principal: Elías Campo Güerri
    Finançador: European Commission
    Codi: H2020-ERC-Sy_2018 (810287)
    Durada: 01/04/2019 - 31/03/2024
  • CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

    Investigador/a principal: Elías Campo Güerri
    Finançador: La Caixa Foundation
    Codi: HR17-00221_ LCF/PR/HR17/52150017
    Durada: 31/12/2018 - 31/12/2022
  • EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine

    Investigador/a principal: Elías Campo Güerri
    Finançador: European Commission
    Codi: CE_H2020-SC1_18_1s 825835
    Durada: 01/01/2019 - 30/06/2023
  • La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.

    Investigador/a principal: Elías Campo Güerri
    Finançador: Generalitat de Catalunya
    Codi: SLT002/16/00374
    Durada: 27/03/2017 - 31/12/2023